Position in ARVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$95,373
-$14,888 QoQ
Shares Held
11,477
+10.3% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#141
of 198 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STATE OF WISCONSIN INVESTMENT BOARD holds $511,704,326 across 163 Biotechnology names. ARVN ranks #156 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
135,798 | $67,454,940 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
55,287 | $34,473,655 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
70,171 | $21,123,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
83,892 | $15,711,293 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
248,821 | $15,018,835 | |
| 6 | MRNA |
Moderna, Inc.
|
207,705 | $14,545,581 | |
| 7 | INSM |
INSMED Inc
|
118,057 | $12,587,237 | |
| 8 | RPRX |
Royalty Pharma plc
|
213,373 | $11,963,824 |
All Filings in ARVN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $95,373 | 11,477 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $110,261 | 10,402 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $357,141 | 41,918 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,126,624 | 153,074 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $546,682 | 77,875 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $953,688 | 49,749 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,109,384 | 45,042 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,859,194 | 69,842 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,217,190 | 53,711 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,103,111 | 51,096 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $866,379 | 44,113 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,638,765 | 66,026 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,861,803 | 68,148 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,551,047 | 45,339 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,047,741 | 46,027 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,868,501 | 44,393 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,246,630 | 63,100 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,969,470 | 60,500 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,971,890 | 60,500 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,027,100 | 52,300 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $3,172,800 | 48,000 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,076,640 | 48,000 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $1,107,309 | 46,900 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,573,026 | 46,900 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,321,840 | 32,800 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||